Coronavirus: WHO declines comment on remdesivir in COVID-19, hopes for best
A top World Health Organization official declined comment on Wednesday on reports that Gilead Science’s remdesivir could help treat COVID-19, the respiratory disease caused by the novel coronavirus, but said that further data was needed.
“I wouldn’t like to make any specific comment on that, because I haven’t read those publications in detail,” Dr Mike Ryan, head of the WHO’s emergencies program, told an online briefing in response to a question, adding it can sometimes take a number of publications to determine a drug’s efficacy.
“Clearly we have the randomized control trials that are underway both in the UK and US, the ‘Solidarity trials’ with WHO. Remdesivir is one of the drugs under observation in many of those trials. So I think a lot more data will come out,” he said.
Ryan added: “But we are hopeful this drug and others may prove to be helpful in treating COVID-19.”
WHO warns of coronavirus impact in Middle East war zonesThe World Health Organization warned on Tuesday of the impact coronavirus could have in Middle Eastern conflict zones and urged other countries in the ... Coronavirus
UN launches global push to accelerate production of coronavirus vaccine, treatmentsThe UN on Friday joined forces with world leaders and the private sector on an initiative to speed up development of COVID-19 vaccines and treatments, ... Coronavirus
Coronavirus: Germany approves live human testing of potential vaccineGermany's vaccines regulator approved live human testing of a potential vaccine against the Covid-19 virus developed by German biotech company ... Coronavirus